论文部分内容阅读
消化系统恶性肿瘤中,肝癌发病率位居前列,目前尚无满意的治疗方法。早期肝癌首选手术治疗,但多数患者就诊时已属中晚期或伴有肝硬变。介入治疗为肝癌提供了一条新的治疗途径。经多年临床应用,已取得较好疗效。1 作用机制介入治疗始于20世纪70年代末期,1979年日本学者首先将碘油作为栓塞剂经肝动脉注入肝脏治疗肝癌。肝癌介入治疗基本原理基于经血管(间接)途径正常肝实质的滋养血管
Digestive malignancies, the incidence of liver cancer among the forefront, there is no satisfactory treatment. Early surgical treatment of liver cancer, but most patients are already in the advanced stage or with cirrhosis. Interventional therapy provides a new therapeutic approach for liver cancer. After years of clinical application, has achieved good results. 1 Mechanism of interventional therapy began in the late 1970s, 1979 Japanese scholars first lipiodol as an embolization agent through the hepatic artery into the liver for the treatment of liver cancer. Fundamentals of interventional therapy for hepatocellular carcinoma based on the nourishing blood vessels of the normal liver parenchyma via the vascular (indirect) pathway